-Completed acquisition of VCN Biosciences, expanding pipeline into oncology-
-VCN-01 received Orphan Drug Designation for retinoblastoma from the U.S. FDA-
Read more at globenewswire.comAll information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
-Completed acquisition of VCN Biosciences, expanding pipeline into oncology-
-VCN-01 received Orphan Drug Designation for retinoblastoma from the U.S. FDA-
Read more at globenewswire.com| Symbol | Last | Chg | %Chg |
|---|---|---|---|
| SYN | 1.0200 | +0.0100 | +0.99% |
| Synthetic Biologics Inc | |||